Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
GDS Holdings
GDS
$7.37B
| $124K | ﹤0.01% |
13,600
-400
| -3% | -$3.65K |
|
3252
Perspective Therapeutics
CATX
$251M
| $123K | ﹤0.01% |
30,675
-6,090
| -17% | -$24.4K |
|
|
RENT
3253
Rent the Runway
RENT
$32.3M
| $123K | ﹤0.01% |
11,620
+1,230
| +12% | +$13K |
|
3254
Hyperfine
HYPR
$106M
| $122K | ﹤0.01% |
+108,681
| New | +$122K |
|
3255
ReNew
RNW
$2.76B
| $122K | ﹤0.01% |
15,900
-26,900
| -63% | -$206K |
|
3256
Aveanna Healthcare
AVAH
$1.76B
| $121K | ﹤0.01% |
45,300
-6,200
| -12% | -$16.6K |
|
|
IMAB
3257
I-MAB
IMAB
$318M
| $121K | ﹤0.01% |
63,800
| – | – |
|
3258
CPI Aerostructures
CVU
$32.7M
| $120K | ﹤0.01% |
44,000
-12,390
| -22% | -$33.8K |
|
|
DWTX
3259
Dogwood Therapeutics, Inc. Common Stock
DWTX
$9.36M
| $119K | ﹤0.01% |
8,268
+7,708
| +1,376% | +$111K |
|
3260
Worksport
WKSP
$22.6M
| $119K | ﹤0.01% |
7,964
+3,944
| +98% | +$58.9K |
|
3261
Inuvo
INUV
$52.3M
| $118K | ﹤0.01% |
27,840
+5,900
| +27% | +$25K |
|
3262
IZEA Worldwide
IZEA
$60.4M
| $118K | ﹤0.01% |
58,903
+6,400
| +12% | +$12.8K |
|
3263
Dakota Gold
DC
$547M
| $117K | ﹤0.01% |
44,600
+5,900
| +15% | +$15.5K |
|
|
IPM
3264
Intelligent Protection Management Corp. Common Stock
IPM
$25M
| $117K | ﹤0.01% |
50,100
+3,780
| +8% | +$8.83K |
|
|
TOUR
3265
Tuniu
TOUR
$107M
| $116K | ﹤0.01% |
172,330
| – | – |
|
3266
Vor Biopharma
VOR
$229M
| $116K | ﹤0.01% |
51,600
+15,100
| +41% | +$33.9K |
|
|
EGIO
3267
DELISTED
Edgio, Inc. Common Stock
EGIO
| $116K | ﹤0.01% |
8,465
-10,834
| -56% | -$148K |
|
|
DDI
3268
DoubleDown Interactive
DDI
$461M
| $115K | ﹤0.01% |
+15,595
| New | +$115K |
|
3269
Diana Shipping Inc. Warrants to Purchase Common Stock (expiring on or about December 14, 2026)
DSX.WS
$15.1M
| $115K | ﹤0.01% |
+411,535
| New | +$115K |
|
3270
First Guaranty Bancshares
FGBI
$124M
| $115K | ﹤0.01% |
10,383
-2,100
| -17% | -$23.3K |
|
3271
Xilio Therapeutics
XLO
$37.8M
| $115K | ﹤0.01% |
209,700
+189,000
| +913% | +$104K |
|
|
AGRX
3272
DELISTED
Agile Therapeutics, Inc
AGRX
| $115K | ﹤0.01% |
+59,200
| New | +$115K |
|
3273
Mexco Energy
MXC
$17.7M
| $114K | ﹤0.01% |
12,500
+2,100
| +20% | +$19.2K |
|
|
GP
3274
GreenPower Motor Co
GP
$11.1M
| $113K | ﹤0.01% |
36,021
+20,421
| +131% | +$64.1K |
|
|
VIVS
3275
VivoSim Labs, Inc. Common Stock
VIVS
$9.59M
| $113K | ﹤0.01% |
8,457
-642
| -7% | -$8.58K |
|